FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho |
| |
Authors: | Kharitonenkov Alexei Dunbar James D Bina Holly A Bright Stuart Moyers Julie S Zhang Chen Ding Liyun Micanovic Radmila Mehrbod Sean F Knierman Michael D Hale John E Coskun Tamer Shanafelt Armen B |
| |
Affiliation: | Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. a.kharch@lilly.com |
| |
Abstract: | Fibroblast growth factor-21 (FGF-21) is a metabolic regulator that can influence glucose and lipid control in diabetic rodents and primates. We demonstrate that betaKlotho is an integral part of an activated FGF-21-betaKlotho-FGF receptor (FGFR) complex thus a critical subunit of the FGF-21 receptor. Cells lacking betaKlotho did not respond to FGF-21; the introduction of betaKlotho to these cells conferred FGF-21-responsiveness and recapitulated the entire scope of FGF-21 signaling observed in naturally responsive cells. Interestingly, FGF-21-mediated effects are heparin independent suggesting that betaKlotho plays a role in FGF-21 activity similar to the one played by heparin in the signaling of conventional FGFs. Moreover, in addition to conferring specificity for FGF-21, betaKlotho appears to support FGF-19 activity and mediates the receptor selectivity profile of FGF-19. All together, these results indicate that betaKlotho and FGFRs form the cognate FGF-21 receptor complex, mediating FGF-21 cellular specificity and physiological effects. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|